1. Home
  2. NCNO vs VCEL Comparison

NCNO vs VCEL Comparison

Compare NCNO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nCino Inc.

NCNO

nCino Inc.

HOLD

Current Price

$23.63

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$40.47

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCNO
VCEL
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
NCNO
VCEL
Price
$23.63
$40.47
Analyst Decision
Buy
Strong Buy
Analyst Count
16
5
Target Price
$26.07
$57.75
AVG Volume (30 Days)
2.5M
446.8K
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
115.15
60.00
EPS
0.18
N/A
Revenue
$594,781,000.00
$276,259,000.00
Revenue This Year
$9.53
$19.40
Revenue Next Year
$8.97
$18.24
P/E Ratio
$127.56
N/A
Revenue Growth
10.01
16.45
52 Week Low
$13.80
$28.95
52 Week High
$31.23
$49.32

Technical Indicators

Market Signals
Indicator
NCNO
VCEL
Relative Strength Index (RSI) 72.58 36.97
Support Level $22.81 $35.45
Resistance Level $26.21 $42.16
Average True Range (ATR) 0.95 1.42
MACD 0.15 -0.28
Stochastic Oscillator 89.30 17.69

Price Performance

Historical Comparison
NCNO
VCEL

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. It is focused on developing the nCino Platform to transform commercial and small business lending for community and regional banks in the U.S. With the company's platform financial institutions can Operate More Intelligently, Improve Efficiency, Elevate Employee and Client Experiences, and Manage Risk and Compliance Continuously Rather Than Reactively. It has built and acquired technology, including SimpleNexus, DocFox, FullCircl, ILT, Visible Equity, FinSuite, and Sandbox Banking, to augment the nCino Platform's capabilities for mortgage lending, onboarding, account opening, indirect auto lending, and analytics and AI. The company operates as one operating segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: